Transaction · 0001415889-25-001819

French Glendon E. III

French Glendon E. III, DIR, reported an open-market or private sale at Pulmonx Corp involving 2221.000000 shares for an estimated $14436.50. Reported holdings after the transaction were 1067427.000000 shares. The stored filing text includes a detected 10b5-1 reference.

Open-market sellSEC transaction code SDIR
LUNGPulmonx Corp
Filing timeJan 21
Trade dateJan 17, 2025
Filing · SECView on SEC
InsiderProfile

Price performance since filing

Close on the filing date, the pre-filing context, and the forward return at standard windows
Price at filing
…
Pre-filing
…
Returns since
…

LUNG price since this filing

30 days of pre-filing context and vertical markers at the filing date plus 7d / 30d / 90d / 180d / 1y afterwards
LUNG since 2025-01-21Filed 591 days ago · 30 days of pre-filing context shaded
Loading…
Filing datePost-filing windows (7d, 30d, 90d, 180d, 1y)30 days of pre-filing context

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
Sell
Code S
Identifier
0001415889-25-001819
Common Stock
Transaction date
Jan 17, 2025
Filed Jan 21, 2025, 10:59 PM · 4d delay
Shares
2.22k sh
$650 per share
Estimated value
-$1.44M
Computed from shares × price
Holdings after
1.06M sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $10.0MLarge $100M
Direct Ownership 10b5-1 Detected
-4score
Filing-only score

-4

Compact filing score computed from stored Form 4 facts. Version v1.

Neutral filing signal

This filing is broadly neutral on the filing-only scale. The Form 4 facts do not strongly tilt positive or negative.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

No officer title

Officer NoDirector Yes10% NoOther No
Footnotes & amended
  1. F1

    The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 10, 2024.

  2. F2

    The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.50 to $6.70, inclusive. The Reporting Person undertakes to provide…

Original filing · 0001415889-25-001819
Related transactions

0 other filings

Same reporting owner
Recent company activity

0 recent txs

LUNG